02675 精鋒醫療-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
09/02/2026Dragon Warrior Investments Limited1213(L)19,580,471(L)5.97
09/02/2026王建辰1711(L)120,068,806(L)36.63
09/02/2026高元倩1711(L)120,068,806(L)36.63
09/02/2026盛利1711(L)31,181,895(L)9.51
08/01/2026王順龍1701(L)31,271,895(L)9.66
08/01/2026赵凯1002(L)17,504,640(L)5.41
08/01/2026王建辰1701(L)+46,868,863(L)46,868,863(L)73.10
08/01/2026Boyu Capital Growth GP I, Ltd.1701(L)4,300,128(L)6.71
08/01/2026XYXY Holdings Ltd.1701(L)4,300,128(L)6.71
08/01/2026广发信德投资管理有限公司1701(L)+17,527,680(L)17,527,680(L)5.42
08/01/2026广发信德中恒汇金(龙岩)股权投资合伙企业(有限合伙)1701(L)+16,359,120(L)16,359,120(L)5.06
08/01/2026成都明晟投资有限公司1002(L)17,504,640(L)5.41
08/01/2026北京君诚合众投资管理合伙企业(有限合伙)1701(L)+16,372,206(L)16,372,206(L)5.06
08/01/2026北京君祺嘉睿企业管理有限公司1701(L)+16,372,206(L)16,372,206(L)5.06
08/01/2026陈浩1701(L)+16,372,206(L)16,372,206(L)5.06
08/01/2026Boyu Capital Growth Fund I, L.P.1701(L)4,300,128(L)6.71
08/01/2026Boyu Capital Growth Fund I, Pte. Ltd.1701(L)4,300,128(L)6.71
08/01/2026童小幪1701(L)4,300,128(L)6.71
08/01/2026王建辰1701(L)+120,068,806(L)120,068,806(L)37.10
08/01/2026君联资本管理股份有限公司1701(L)+16,372,206(L)16,372,206(L)5.06
08/01/2026高元倩1701(L)+46,868,863(L)46,868,863(L)73.10
08/01/2026Dragon Warrior Investments Limited1701(L)19,580,471(L)6.05
08/01/2026广发证券股份有限公司1701(L)+17,536,580(L)17,536,580(L)5.42
08/01/2026盛利1701(L)31,181,895(L)9.64
08/01/2026Intelligent Spark Investment Pte. Ltd.1701(L)4,300,128(L)6.71
08/01/2026高元倩1701(L)+120,068,806(L)120,068,806(L)37.10
08/01/2026Boyu Group, LLC1701(L)4,300,128(L)6.71
08/01/2026拉萨君祺企业管理有限公司1701(L)+16,372,206(L)16,372,206(L)5.06
 1  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.